News Column

At Investment-In-Innovation (IN3) Medical Device 360 Degrees Dublin, the Debate Will Continue: Should Medtech Companies Start-Up in the U.S. or Europe?

Apr 8 2013 12:00AM

Marketwire

LogoTracker

DUBLIN, IRELAND -- (Marketwired) -- 04/08/13 -- Elsevier Business Intelligence, publisher of "The Gray Sheet" and the medtech industry's leading provider of strategic partnership and investment conferences, will host the 'Investment-in-Innovation (IN3) Medical Device 360 degrees Dublin' partnering and investment conference on April 16-18, 2013, at the The Shelbourne Dublin. This special event will bring together a diverse group of medtech's key thought leaders from among corporate business development execs, family office, venture capital and angel investors, start-up entrepreneurs and industry pioneers. Program highlights will include:

Keynote Address on Behalf of Eucomed Creating Value in European Healthcare: Transforming the Medtech Business Model to Deliver Value-Based Innovations: Thierry Herbreteau, President, Europe Middle East Africa and Canada (EMEAC), St. Jude Medical.

Synergies between U.S. and European Companies in Medtech Development and Commercialization Given the challenges in raising capital for emerging medtech opportunities and getting regulatory approval, more and more U.S. companies are looking to develop and launch their products and start their companies in Europe; at the same time, the U.S. remains the largest medical device market in the world with the strongest infrastructure for small companies looking to build quickly. Further, most of the corporate exit decisions are taken in the U.S. offices of medtech strategics. So is the U.S. the best place to be? Or Europe? Or is it a question of building on the advantages that each region offers and getting the best of both? Factors that influence the decision include regulatory strategy, market size, etc. This session will explore the subject with executives from both geographies, each of whom has taken a different approach to that issue.

Confirmed panelists will include: David Cassak (moderator), Vice President, Content, Elsevier Business Intelligence; Steve Levin (moderator), Editor-in-Chief, Elsevier Business Intelligence; Simon Cartmell, Venture Partner, Imperial Innovations; Hanson Gifford, CEO, The Foundry; James Greene, CEO, APICA Cardiovascular; Derek Young, CEO, i360 Medical.

In addition to all of the customary conference benefits, presenting company CEOs will have the opportunity to be interviewed on camera, at no charge, for a 3-minute exclusive video in which they may discuss their company and technology. These interviews will be featured post-conference at www.in3tv.com, to which a link will be provided to participating companies for their unrestricted use; availability of these video interviews will be broadly promulgated within the medtech industry. All one-on-one interviews with presenting-company CEOs will take place at, and during the IN3 Dublin conference and be organized by medtech PR/IR expert Ronald Trahan, President of Ronald Trahan Associates, Inc. Videotaping will take place on a scheduled basis only, on one day only of the event: Wednesday, April 17, from 13:00-17:30 local time. To schedule the free on-camera interviews contact rctrahan@ronaldtrahan.com, or call +1-508-359-4005, x108.

IN3 Dublin will feature presentations by 39 early development- to commercial-stage start-up device companies seeking funding and/or strategic partnership. Confirmed presenters to date include: Access Bio, Aerogen, Aleva Neurotherapeutics, AltaScience, APICA Cardiovascular, Calon Cardio-Technology, CapeRay, Chronix Biomedical, Crescent Diagnostics, Dialog Devices, Expanding Orthopedics, FBC Device, Glysure, Humedics, i360medical, Infandx, Life Care Medical Devices, Mainstay Medical, Mederi Therapeutics, MedLumics, Miracor Medical Systems, Nano Bridging Molecules, Neuravi, NeuroMed Devices, Nordocs, Novate Medical, Quanta Fluid Solutions, Regenesis Biomedical, Respinova, Revision Optics, ROWIAK, Simpirica Spine, SpineLab, Specialty Scanners, Technopath, Valtronic, Vascular Flow Technologies, Veryan Medical, and Vivasure Medical.

Event co-sponsors include Ronald Trahan Associates Inc., Aptiv Solutions, Enterprise Ireland, Eucomed, Eugene F. Collins, IMDA, KPMG, Life Science Intelligence, Marketwire, MassMEDIC, Mass Medical Angels, Medmarc. Meditech, Seroba Kernel and Pharma Connections.

Visit www.in3dublin.com for full conference and registration details. Emerging medtech companies that would like to apply to present in Dublin should contact Kayleen Kell at 949-797-7142, or email k.kell@elsevier.com

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.



Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108





Source: Marketwire